![]() Argenx Argenx is a clinical-stage biotechnology company developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. | |||
Founding Date | Founding Date 2016 | Founding Date 1988 | Founding Date 2008 |
Type | Type Private | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations San Diego, US HQ | Locations Pécs, HU HQ | Locations Gent, BE HQ Minato City, JP Breda, NL Genève, CH Boston, US |
Employees | Employees 10 | Employees 57 | Employees 1,599 |
Funding | |||
Total funding raised | Total funding raised $ 155m | Total funding raised N/A | Total funding raised $ 396.8m |

Argenx is a clinical-stage biotechnology company developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer.
View company